Research snapshot · 7/8/26

FTREFortrea

WATCH

Conviction●●○○○2 of 5

Research target$19.35Snapshot target

Thesis statusWEAKENEDLast reviewed 7/8/26

Market cap1.63BSnapshot value

Research history

What changed

Jul 11, 2026

Conviction
1 → 2

Jul 11, 2026

Target
— → $19.35

Jul 11, 2026

Thesis status
NEEDS_MORE_DATA → WEAKENED

Jul 11, 2026

Last reviewed
Not reviewed → 7/8/26

Jul 8, 2026

Target
— → $19.35

The thesis

Full-service CRO, spun from Labcorp. Turnaround story — lower margin, smaller scale than IQV/ICLR/MEDP. Higher risk, higher potential upside.

Catalysts

Turnaround execution under independent management; biotech funding recovery; FSP model adoption; potential M&A target in consolidating CRO market.

What breaks it

Turnaround execution risk; smaller scale creates competitive disadvantage vs IQV/ICLR; margin pressure; Labcorp spin-off overhang.

Social sentiment

needs X/Reddit sentiment sweep

Snapshot · 7/8/26

Smart money

🟢 Lean-Bull · ins-$0.4M · 13F 19+/6- · short↓0.2

Snapshot · 7/8/26